[25-007852] DR. Larochelle and DR. Keji zhao requires reagents and kits for specified human cells in order to continue ongoing projects
Ended Purchase Order Awarded
- Contract number
- 75N92025P00158
- Awardee
-
Stemcell Technologies Inc. UEI ELPMWCGFK518 Part of Stemcell Tecnologies
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,192
Award facts
- Contract value 100% obligated
- $10,191.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Kent, WA 98032, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung, and Blood Institute awarded a $10,191.59 firm fixed-price purchase order to Stemcell Technologies Inc. on April 9, 2025, to procure reagents and kits for specified human cells supporting ongoing research projects led by Dr. LaRochelle and Dr. Keji Zhao. The contract, which will be completed by June 9, 2025, was not set aside for small businesses. Stemcell Technologies Inc., a Kent, Washington-based subsidiary of the Canadian biotechnology firm Stemcell Technologies, specializes in providing advanced biological research products including cell isolation kits, cell culture media, and specialized research-grade reagents to federal research institutions.
This purchase order falls under the company's larger $10 million Blanket Purchase Agreement with the National Institutes of Health Office of Logistics and Acquisition Operations, which runs through December 31, 2025. The BPA enables streamlined procurement of biological materials and laboratory supplies across multiple NIH institutes and centers, including the National Heart, Lung, and Blood Institute. Stemcell Technologies Inc. has consistently supported federal biomedical research initiatives in areas such as immunology, infectious diseases, and stem cell research through similar contract vehicles with various health-related federal agencies.
Quick answers
Who was awarded contract 75N92025P00158?
75N92025P00158 was awarded to Stemcell Technologies Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on April 9, 2025.
How much is contract 75N92025P00158 worth?
The government has obligated $10,192 on 75N92025P00158.
Was contract 75N92025P00158 competed?
The extent of competition for 75N92025P00158 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award